Sphenopalatine Ganglion Block: Effective Migraine Relief

Research Summary

A recent study published in Neurologia Neurochirurgia Polska explored the effectiveness of sphenopalatine ganglion blockade in treating episodic migraine, a debilitating condition characterized by severe headaches. This research included 31 patients, predominantly women, aged 22-55, who underwent the procedure using the Sphenocath applicator with 4% lidocaine. Participants were evaluated with various scales, including the visual analogue scale (VAS), migraine disability assessment scale (MIDAS), and headache impact test-6 (HIT-6). Results showed significant pain reduction and improved daily functioning after treatment, suggesting that the sphenopalatine ganglion block could serve as an effective alternative or complement to traditional migraine medications.

Study Details

📄 Title: Assessment of the effectiveness of sphenopalatine ganglion blockade in the treatment of migraine.

👥 Research Team: Kierońska-Siwak S et al.

📚 Published In: Neurol Neurochir Pol

📅 Publication Date: 2025 Nov 20

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.